Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
Financing › Details

4SC–SEVERAL: investment, 201906 capital increase €11m with 4.677m new shares at €2.37/share

 

Period Period 2019-06-11 ï¿½ 2019-06-28
  Successor 4SC–SEVERAL: investment, 201910 capital increase €22.4m net €22m with 10.65m new shares at €2.1/share with subscription rights
Organisation Money taker 4SC AG (FSE: VSC)
  Group 4SC (Group)
Products Product small-molecule cancer drug
  Product 2 investment banking
Document Source 4SC AG. (6/28/19). "Press Release: 4SC AG Secures EUR 11 Million from Capital Increase [Ad hoc, not for US, AU, CA, JP, ZA, et al.]". Planegg-Martinsried.
     

   
Record changed: 2019-10-12

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for 4SC (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px




» top